Apyx Medical Corporation (APYX) Financials

APYX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 63.0 million 49.9 million
Dec. 31, 2025 66.8 million 52.0 million
Sept. 30, 2025 57.4 million 51.3 million
June 30, 2025 58.2 million 50.7 million

APYX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -632000 312000
Dec. 31, 2025 -2.8 million 500000
Sept. 30, 2025 -4.1 million 530000
June 30, 2025 -1.5 million 520000

APYX Net Income

No data available :(

APYX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 31.1 million 35.1 million 3.9 million
Dec. 31, 2025 31.7 million 34.8 million 4.1 million
Sept. 30, 2025 25.1 million 34.6 million 4.2 million
June 30, 2025 29.3 million 34.4 million 4.7 million

APYX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 42.2 million
Dec. 31, 2025 42.2 million
Sept. 30, 2025 40.7 million
June 30, 2025 40.7 million

APYX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 60000 765000 3.6 million -
Dec. 31, 2025 275000 944000 11.0 million -
Sept. 30, 2025 518999 801000 8.3 million 6.8 million
June 30, 2025 265000 824000 8.8 million -

APYX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 12.5 million 7.8 million
Dec. 31, 2025 19.2 million 21.2 million
Sept. 30, 2025 12.9 million 4.6 million
June 30, 2025 11.4 million 4.3 million

APYX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

APYX

Price: $3.92

52 week price:
1.59
5.08

Earnings Per Share: -0.22 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 194062

Market Capitalization: 180.2 million

Links: